Concepedia

Chirapong Uthaisin

CU

5

Publications

408

Citations

5

H-Index

2011

Active since

Affiliations

Maesot General Hospital(Current)

Medicines for Malaria Venture

National Institute of Malaria Research

Shoklo Malaria Research Unit

Novartis (United States)

Chirapong Uthaisin is an author at Maesot General Hospital specializing in drug discovery, pharmacology, and malaria.

Top concepts

Publications per year

2011–2023

5

Publications

5

Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria

Ronnatrai Rueangweerayut, Aung Pyae Phyo, Chirapong Uthaisin et al. · New England Journal of Medicine · 2012 · 108 citations · Full text

Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria

Nicholas J. White, Tran Thanh Duong, Chirapong Uthaisin et al. · New England Journal of Medicine · 2016 · 107 citations · Full text

Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial

Poravuth Yi, Duong Socheat, Ronnatrai Rueangweerayut et al. · PLoS ONE · 2011 · 105 citations · Full text

Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria

Anna M. Leitgeb, Prakaykaew Charunwatthana, Ronnatrai Rueangveerayut et al. · PLoS ONE · 2017 · 52 citations · Full text

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial

Bernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa et al. · The Lancet Infectious Diseases · 2023 · 36 citations

, , +3

Rows per page

1–5 of 5